• Phase 3 Trial of Translarna’s Long-term Efficacy Enrolling Duchenne MD Patients with Nonsense Mutations
  • Growing Thicker Skin
  • New Device Measures Cell Strength Faster, More Accurately, Aiding in Search for MD Therapies
  • 4th STRIVE Awards Program Opens to Groups Promoting DMD Advocacy and Care, PTC Announces
  • Catabasis Announces Global Phase 3 Trial of Edasalonexent for DMD Boys
  • New CRISPR Strategy Corrects Wider Range of Mutations Responsible for DMD
  • Bodysuit Will Use Artificial Intelligence to Track Movement in DMD Patients
  • Santhera Making Raxone Available to DMD Patients in US Under Expanded Access Program
  • Protecting Yourself Against This Year’s Flu Virus
  • FDA Grants RMAT Designation to Capricor Cell Therapy for Duchenne
  • Researchers Use Artificial Chromosomes to Deliver Gene Therapy for DMD
  • Skyhawk Secures $8M in Seed Funding to Advance Small Molecule Therapies Targeting RNA